Table 1 Baseline characteristics of cases with developed stage 1 or higher AKI
Characteristics | Analysis 1 (n = 766) | Analysis 2 (n = 212) |
|---|---|---|
Age (years), mean (SD) | 62.9 (16.3) | 65.4 (17.0) |
Female, n (%) | 329 (43.0) | 100 (47.1) |
Baseline eGFR (mL/min/1.73 m2), n (%) | ||
 More than 60 | 502 (65.5) | 130 (61.3) |
 30–60 | 200 (26.1) | 59 (27.4) |
 Less than 30 | 64 (8.4) | 23 (10.8) |
Days of observation, median (IQR) | 1,624 (961–2,111) | 945 (343–1,657) |